These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7296509)

  • 1. Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease.
    Björkholm M; Wedelin C; Holm G; Johansson B; Mellstedt H
    Cancer; 1981 Nov; 48(9):2010-5. PubMed ID: 7296509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
    Björkholm M; Askergren J; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
    Wedelin C; Björkholm M; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Br J Cancer; 1982 Jan; 45(1):70-9. PubMed ID: 6977367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
    van Rijswijk RE; Sybesma JP; Kater L
    Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro lymphocyte response to the phytomitogens in untreated and treated patients with Hodgkin's disease.
    Romagnani S; Amadori A; Biti G; Bellesi G; Ricci M
    Int Arch Allergy Appl Immunol; 1976; 51(3):378-89. PubMed ID: 1279027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic profile of patients with cured Hodgkin's disease.
    Bjorkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.
    Wagener DJ; Geestman E; Wessels HM
    Cancer; 1975 Jul; 36(1):194-8. PubMed ID: 1203846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
    van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
    Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted?
    Björkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1978 Apr; 20(4):297-305. PubMed ID: 653309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological defects in healthy twin siblings to patients with Hodgkin's disease.
    Björkholm M; Holm G; De Faire U; Mellsted H
    Scand J Haematol; 1977 Oct; 19(4):396-404. PubMed ID: 562530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
    Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
    Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease.
    Björkholm M; Holm G; Johansson B; Mellstedt H; Möller E
    Tissue Antigens; 1975 Oct; 6(4):247-56. PubMed ID: 1081776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of radiochemotherapy and splenectomy on lymphoid subclasses in patients with Hodgkin's lymphoma in complete remission].
    Leoni P; Montroni M; Montillo M; Salvi A; Centurioni R; Fanciulli E
    G Clin Med; 1981 Oct; 62(10):685-92. PubMed ID: 6977469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.